These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36130191)

  • 1. The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
    Whalen ME; Kajubi R; Goodwin J; Orukan F; Colt M; Huang L; Richards K; Wang K; Li F; Mwebaza N; Aweeka FT; Parikh S
    Clin Infect Dis; 2023 Feb; 76(3):443-452. PubMed ID: 36130191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
    Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
    J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
    Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
    J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
    McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
    Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O
    Malar J; 2011 Aug; 10():237. PubMed ID: 21838909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
    Katrak S; Gasasira A; Arinaitwe E; Kakuru A; Wanzira H; Bigira V; Sandison TG; Homsy J; Tappero JW; Kamya MR; Dorsey G
    Malar J; 2009 Nov; 8():272. PubMed ID: 19948038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.
    Ngasala B; Chiduo MG; Bushukatale S; Mmbando BP; Makene T; Kamugisha E; Ahmed M; Mandara CI; Francis F; Mahende MK; Kavishe RA; Muro F; Ishengoma DS; Mandike R; Molteni F; Chacky F; Kitojo C; Greer G; Bishanga D; Chadewa J; Njau R; Warsame M; Kabula B; Nyinondi SS; Reaves E; Mohamed A
    Malar J; 2024 Apr; 23(1):95. PubMed ID: 38582830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
    Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG
    Malar J; 2008 Jun; 7():106. PubMed ID: 18547415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
    Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
    Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Westercamp N; Owidhi M; Otieno K; Chebore W; Buff AM; Desai M; Kariuki S; Samuels AM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0020722. PubMed ID: 36036611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
    Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
    PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
    Assefa DG; Zeleke ED; Bekele D; Tesfahunei HA; Getachew E; Joseph M; Manyazewal T
    Malar J; 2021 Apr; 20(1):174. PubMed ID: 33794897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
    Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
    Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
    Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
    BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.